Quick Answer
Vivos Therapeutics, Inc. reported Earnings Per Share Diluted of $2.22 (loss) per share for the year ending 2024.
- Vivos Therapeutics, Inc. showed an increase of +80.1% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Vivos Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2022 to 2024), Vivos Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 91.4%.
- Historical annual values: Fiscal year 2024: $2.22 (loss) per share | Fiscal year 2023: $11.14 (loss) per share | Fiscal year 2022: $25.90 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: